DIN 02171929 — TEVA-5 ASA 400 MG
TEVA-5 ASA is a tablet (enteric-coated) of Mesalazine marketed by TEVA CANADA LIMITED. The full Mesalazine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02171929
- Brand name
- TEVA-5 ASA
- Active ingredient
- Mesalazine
- Strength
- 400 MG
- Dosage form
- TABLET (ENTERIC-COATED)
- Route
- ORAL
- Manufacturer
- TEVA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Aminosalicylate (5-ASA) gastrointestinal anti-inflammatory agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Mesalazine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02297558 | MEZAVANT | 1.2 G | TABLET (DELAYED- AND EXTENDED-RELEASE) | TAKEDA CANADA INC | MARKETED |
| 02474018 | MEZERA | 1 G | SUPPOSITORY | AVIR PHARMA INC. | MARKETED |
| 02474026 | MEZERA | 1 G | FOAM | AVIR PHARMA INC. | MARKETED |
| 02545012 | MEZERA | 1 G | TABLET (DELAYED-RELEASE) | AVIR PHARMA INC. | MARKETED |
| 02524481 | MEZERA | 500 MG | TABLET (DELAYED-RELEASE) | AVIR PHARMA INC. | MARKETED |
| 02529610 | OCTASA | 1600 MG | TABLET (DELAYED-RELEASE) | TILLOTTS PHARMA AG | MARKETED |
| 02465752 | OCTASA | 800 MG | TABLET (DELAYED-RELEASE) | TILLOTTS PHARMA AG | MARKETED |
| 02153521 | PENTASA | 1 G | SUSPENSION | FERRING INC | MARKETED |
| 02153564 | PENTASA | 1 G | SUPPOSITORY | FERRING INC | MARKETED |
| 02399466 | PENTASA | 1 G | TABLET (EXTENDED-RELEASE) | FERRING INC | MARKETED |
| 02153556 | PENTASA | 4 G | SUSPENSION | FERRING INC | MARKETED |
| 02099683 | PENTASA | 500 MG | TABLET (EXTENDED-RELEASE) | FERRING INC | MARKETED |
| 02242146 | SALOFALK | 1000 MG | SUPPOSITORY | ABBVIE CORPORATION | MARKETED |
| 02112795 | SALOFALK | 2 G | SUSPENSION | ABBVIE CORPORATION | MARKETED |
| 02112809 | SALOFALK | 4 G | SUSPENSION | ABBVIE CORPORATION | MARKETED |
| 02112760 | SALOFALK | 500 MG | SUPPOSITORY | ABBVIE CORPORATION | MARKETED |
| 02112787 | SALOFALK | 500 MG | TABLET (DELAYED-RELEASE) | ABBVIE CORPORATION | MARKETED |
| 02562367 | ZDS-MESALAMINE SUPPOSITORIES | 1000 MG | SUPPOSITORY | ZYDUS LIFESCIENCES LIMITED | MARKETED |